Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Dhg Pharmaceutical Joint-Stock Co
Note Receivable
Dhg Pharmaceutical Joint-Stock Co
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Note Receivable
₫5.6B
|
CAGR 3-Years
90%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Note Receivable
₫6.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
91%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Note Receivable
₫964.3m
|
CAGR 3-Years
168%
|
CAGR 5-Years
81%
|
CAGR 10-Years
29%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Note Receivable
₫4B
|
CAGR 3-Years
67%
|
CAGR 5-Years
60%
|
CAGR 10-Years
42%
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Note Receivable
₫931.5m
|
CAGR 3-Years
524%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Dhg Pharmaceutical Joint-Stock Co
Glance View
DHG Pharmaceutical JSC engages in the production, sale, and trade of pharmaceutical products. The company is headquartered in Can Tho, Can Tho and currently employs 2,770 full-time employees. The company went IPO on 2006-12-21. The firm manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
See Also
What is Dhg Pharmaceutical Joint-Stock Co's Note Receivable?
Note Receivable
5.6B
VND
Based on the financial report for Dec 31, 2025, Dhg Pharmaceutical Joint-Stock Co's Note Receivable amounts to 5.6B VND.
What is Dhg Pharmaceutical Joint-Stock Co's Note Receivable growth rate?
Note Receivable CAGR 5Y
87%
Over the last year, the Note Receivable growth was 2 636%. The average annual Note Receivable growth rates for Dhg Pharmaceutical Joint-Stock Co have been 90% over the past three years , 87% over the past five years .
